We examined the role of Hsp90 in expression and maturation of wild-type (WT) and mutant ether-a-go-go related gene (HERG) proteins by using Hsp90 inhibitors, geldanamycin (GA) and radicicol, and Hsp90 overexpression.
Introduction
The human ether-a-go-go related gene (HERG) confers the rapidly activating component of the delayed rectifier potassium current (I Kr ) in cardiac myocytes. I Kr is activated during the plateau phase of the ventricular action potential, leading to repolarization of the membrane potential. 1 Mutations of HERG cause long QT syndrome 2 (LQT2). 2 -5 Most of the mutant HERG proteins in LQT2 have trafficking defects so that they are retained in the endoplasmic reticulum (ER) and degraded via the ubiquitin-proteasome system (UPS). Therefore, stabilization (facilitation of folding and alleviation of degradation) of the mutant proteins to ameliorate trafficking defects and increase I Kr might be of therapeutic value for patients with LQT2. Heat shock proteins (Hsps) are required for folding newly synthesized proteins; they achieve a competent state for folding of client proteins that are believed to have difficulties in reaching their native conformation. 6, 7 Voltage-gated potassium channels such as HERG channel (Kv11.1) 8 and Kv1.5 9 have been reported to belong to the set of client proteins stabilized by Hsp family proteins. HERG proteins contain Per ARNT Sim (PAS) domain and cyclic-nucleotide binding domain (cNBD) in its N-and C-terminus, both of which are the binding sites for Hsps. 8, 10 Hsp90 and Hsp/c70 are involved in folding of HERG proteins, as well as the cystic fibrosis transmembrane conductance regulator (CFTR), via binding to their cNBD or PAS domain. 11 -13 HERG proteins are folded by a large multi-chaperone complex with Hsp90/Hsp/c70 in concert with smaller co-chaperones such as Hsp70-Hsp90 organizing protein (Hop), FK506-binding protein 38 (FKBP38), or Hdj1/2. 14 -20 It has also been shown that an Hsp90 inhibitor, geldanamycin (GA) which occupies the ATP binding site of Hsp90 and interrupts its ATPase cycle, suppressed maturation of HERG proteins and facilitated their degradation through UPS. 14,21 -23 This finding suggests a pivotal role of Hsp90 in preventing ubiquitination and degradation of HERG proteins. The ubiquitin ligase (E3) mediates ubiquitination of chaperon-bound client proteins in conjunction with E2 enzyme of the Ubc 4/5 family. 24 -26 C-terminus of Hsp70-interacting protein (CHIP) is an E3 ubiquitin ligase crucial for ubiquitination of small Hsp client proteins, 27 including CFTR 28 and wild-type (WT) HERG proteins; however, it remains unknown how the interaction with CHIP and ubiquitination of HERG proteins are affected by Hsp90, or whether CHIP is involved in ubiquitination of the mutant HERG proteins. The major aim of the present study was to determine (i) how and to what extent Hsp90 affects ubiquitination and degradation of WT and mutant HERG proteins, and (ii) how CHIP is involved in the modulation of HERG protein ubiquitination by Hsp90. We examined effects of the Hsp90 inhibitor GA and Hsp90 overexpression on the expression levels of both WT HERG proteins and the mutants identified in LQT2 patients. We found that CHIP bound to the immature form of the mutants as well as WT HERG proteins, leading to their degradation through UPS. Hsp90 inhibited the binding of CHIP to the immature form of WT and mutant HERG proteins, thereby prevented their degradation.
Methods

Transient expression of HERG proteins, Hsp90, and CHIP in cultured cells
Expression constructs pcDNA3/HERG-FLAG and HERG(1122fs/147)-FLAG 29 were engineered by ligating an oligonucleotide encoding a FLAG epitope to the carboxyl terminus of WT or 1122fs/147 mutant HERG cDNA. Missense HERG mutations in the cytoplasmic domain, R752W, F805C, S818L, V822M, R825W, were introduced into pcDNA3/HERG-FLAG by site-directed mutagenesis. We used HEK293 cells for transient expression of HERG-FLAG proteins. Cells were maintained in Dullbecco's modified Eagle medium (Gibco BRL)/10% foetal bovine serum (Gibco BRL) at 378C in a 5% CO 2 incubator, and were transfected by using Lipofectamine (Gibco BRL). Cells on 6 cm dishes were transfected with WT or mutant HERG-FLAG cDNA (2 mg) and pcDNA3/Hsp90 (2 mg) together with the plasmid vector to express the enhanced green fluorescent protein (pEGFP) (0.5 mg), keeping the total amount of cDNA at 4.5 mg. Cells were assayed 48 h after transfection. For expression of CHIP, either WT or mutant HERG-FLAG plasmid (0.5 mg) and pcDNA3/CHIP (0.125-2.0 mg) together with pEGFP (0.5 mg) were transfected. We also used HL-1 mouse cardiomyocytes to evaluate the effects of Hsp90 and CHIP on endogenous mouse ERG. Transfection into HL-1 cells was performed using Lipofectamine 2000 reagent, of which efficiency of transfection based on GFP fluorescence was 70%.
Western blotting and immunoprecipitation
Cells were scraped into lysis buffer (PBS/1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mg/mL aprotinin, 10 mg/mL leupeptine, 10 mg/mL pepstain, and 1 mM phenylmethylsulfonylfluoride), lysed by sonication, and insoluble materials were removed by centrifugation. Protein concentrations were determined with a BCA protein assay kit (Piearce, Biotechnology, Rockford, IL, USA).Ten mg protein was separated on 7.5% SDS -PAGE and electrotransferred to a PVDF membrane. Membranes were probed with antibodies against FLAG (1:1000, Cosmo Bio), GFP (1:4000, Molecular Probes), b-actin (1:5000, Oncogene), Hsp90 (1:1000), CHIP (1:1000), and ubiquitin (1:1000); their signals were estimated using an ECL system. GFP was used as a transfection efficacy control and b-actin was used as a loading control. Immunoprecipitation was carried out in PBS/1% Triton X-100, 0.5% SDS, 0.25% sodium deoxycholate, 1 mM EDTA, and protease inhibitors for 2 h at 48C. Immune complexes were collected with protein G agarose (Pharmacia, Uppsala, Sweden), and bound proteins were analysed by SDS-PAGE followed by immunoblotting. Band densities were quantified using an NIH image J software. The all image densities of western blotting were quantified and normalized to their image densities of b-actin level and control.
Real-time reverse transcription-PCR (RT-PCR)
Total RNAs were extracted from HEK293 cells using an RNeasy Plus mini kit (QIAGEN) and subjected to the RT-PCR assay (Prime Scrips RT-PCR Kit, Takara). RNA samples were treated with DNase I (Promega) to eliminate genomic DNA, and cDNA was synthesized using SuperScript TM II reverse transcriptase (Gibco BRL). Quantitative RT-PCR (qRT-PCR) was performed with the 7900HT Fast Real-Time PCR System, 384-well plate according to the manufacturer's instructions (Applied Biosystems, CA, USA). Primers used are: HERG forward primer: GGGCTCCATCGAGATCCT, reverse: AGGCCTTGCATACAGGTTCA; b-actin forward primer: GCACCCAGCACAATGAAGA, reverse: CGATCCACACGGAGTACTTG.
Data analysis was performed with the SDS software version 3.2 (Applied Biosystems).
Immunofluorescence
HEK293 cells were transfected with pcDNA3/WT HERG-FLAG or pcDNA3/mutant HERG-FLAG and pDsRed2-ER (Clontech), pDsRedMonomer-Golgi (Clontech), or pPM-mKeima-Red (BML) constructs, together with pcDNA3/Hsp90. 24 h after transfection, cells were fixed with 4% paraformaldehyde/PBS and then permeabilized with 0.5% Triton X-100. They were incubated for 1 h at room temperature with a primary Hsp90 prevents CHIP-HERG protein interaction antibody (FLAG, 1:1000; HERG, 1:100). After blocking in 3% albumin, bound antibody was visualized with Alexa Fluor 488 or 546-conjugated mouse or rabbit secondary antibody (1:2000) , and images were collected with a TCS SP2 confocal microscope (Leica, Tokyo, Japan). Fluorescent images were prepared from data files and quantified with software installed in the TCS SP2 confocal microscope. Signal intensities were at least half saturation. Images were obtained by taking images 0.5 mm through the cell. To quantify HERG-FLAG signals, the images of HERG-FLAG signals were cropped with regard to the distribution of each marker protein (DsRed2-ER, DsRedMonomer-Golgi or PM-mKeima-Red) using the Photoshop CS3 software (Adobe Systems, USA). The signal intensities in the cropped images were quantified by the Image J software (NIH, USA).
Electrophysiological recordings
Transfected cells were visualized by GFP fluorescence and subjected to the whole-cell patch clamp to measure WT or mutant HERG channel-mediated membrane current corresponding to I Kr . Currents were elicited every 6 s by 3-s test pulses ranging from -40 to +50 mV (in 10 mV increments) followed by repolarization to -50 mV for 3 s. The holding potential was -80 mV.
Voltage dependence data for the peak amplitude of tail currents (I tail ) recorded at -50 mV after repolarization were fitted by a Boltzmann equation,
where V is the test pulse potential. I max , V h , and k denote the maximum attainable current, half-maximum test pulse potential, and slope factor, respectively.
Statistical analysis
All data are expressed as means + SEM. For statistical analysis, a one-sample location test of the population mean, Student's t-test and repeated measures analysis of variance (two-way ANOVA) were used, with P , 0.05 being considered statistically significant.
Results
Effects of HSP90 on maturation of WT HERG proteins
We first examined effects of Hsp90 on maturation of WT HERG-FLAG proteins expressed in HEK293 cells. The Hsp90 inhibitor GA (1 mM) decreased the mature form of the HERG-FLAG protein (155 kDa) and increased its immature form (135 kDa); Hsp90 overexpression restored the mature form along with further increase in the immature form in the cells treated with GA ( Figure 1A) , as confirmed by quantitative analysis ( Figure 1B ). Abundance of mRNA of HERG-FLAG was comparable between cells with and without co-transfection of Hsp90 (see Supplementary material online, Figure S1 ). The distribution of HERG-FLAG proteins and endogenous Hsp90 was examined in HERG-FLAG transfected cells by immunofluorescence. Anti-FLAG staining revealed the localization of HERG-FLAG proteins in a reticular pattern throughout the cytosol, obviously in the ER and in a perinuclear pattern throughout the nuclear envelope; anti-Hsp90 staining also revealed the localization of endogenous Hsp90 in a reticular and perinuclear pattern, indicating co-localization of endogenous Hsp90 with HERG-FLAG proteins (see Supplementary material online, Figure S2 ). Anti-FLAG and anti-HERG staining of cells co-expressing HERG-FLAG and HERG proteins showed essentially the same distribution (see Supplementary material online, Figure S3 ), excluding a potential effect of the FLAG epitope on the intracellular localization of HERG proteins.
Effects of Hsp90 on localization and trafficking of WT HERG proteins
We next examined how Hsp90 could affect localization and trafficking of WT HERG-FLAG proteins, and HERG channel-mediated membrane currents. Confocal images indicated that the inhibition of Hsp90 by GA significantly reduced the signals of HERG-FLAG proteins in the Golgi and on the cell membrane, but increased that of HERG-FLAG in the ER; Hsp90 overexpression restored the signals of HERG-FLAG proteins as confirmed by quantitative analysis (see Supplementary material online, Figure S4A -D). Both the HERG-FLAG channel-mediated peak and tail currents recorded in cells transfected with HERG-FLAG plasmid alone were much smaller in the presence of GA than in the absence. Co-expression of Hsp90 increased both peak and tail current amplitudes in the presence of GA, which was confirmed by quantitative analysis (see Supplementary material online, Figure S5 ). Taken together, GA-induced inhibition of Hsp90 impaired the maturation and trafficking of HERG proteins and decreased the expression of functional HERG proteins, which could be normalized by Hsp90 overexpression.
Effects of Hsp90 on degradation of WT HERG proteins via the interaction with CHIP
We further examined the effects of Hsp90 on ubiquitination and degradation of WT HERG proteins in relation to their interaction with CHIP. The ubiquitinated form of WT HERG proteins was increased by GA and decreased by Hsp90 overexpression even in the presence of GA ( Figure 1A) . Treatment with an authentic proteasome inhibitor, MG132 (50 mM), mimicked the effect of Hsp90 on the amount of the immature form in the presence of GA ( Figure 1C) . These results indicate that Hsp90 inhibits degradation of HERG proteins through interaction with UPS. Radicicol (20 mM), another inhibitor of Hsp90, had the similar actions on WT HERG-FLAG maturation (see Supplementary material online, Figure S6 ). Since CHIP is an E3 ubiquitin ligase crucial for ubiquitination of small Hsp client proteins, 27 we hypothesized that Hsp90 prevented the interaction between CHIP and WT HERG-FLAG proteins. Immunoprecipitation experiments in Figure 1A show that the CHIP/HERG-FLAG complex was increased by GA along with a decrease in the Hsp90/ HERG-FLAG complex and was decreased by Hsp90 overexpression along with an increase in the Hsp90/HERG-FLAG complex in cells treated with GA, which was confirmed by quantitative analysis ( Figure 1B) . This suggests that association of CHIP with HERG-FLAG is facilitated by inhibition of Hsp90 in the cells treated with GA. Next, we examined the dose-dependent effects of CHIP on HERG-FLAG proteins in transfected cells with or without inhibition of Hsp90 by GA. CHIP overexpression reduced both mature and immature HERG-FLAG proteins in a dose-dependent manner in the presence of GA (Figure 2A ), but not in the absence of GA ( Figure 2B ). MG132 increased the immature form of HERG-FLAG proteins in cells co-expressing CHIP in the presence of GA, which was confirmed by quantitative analysis ( Figure 2C ). These results indicated that the decrease in the immature form of HERG-FLAG proteins caused by CHIP was attributable to their degradation via UPS. Taken together, Hsp90 could suppress the formation of CHIP/WTHERG protein complex and its degradation though UPS.
Effects of Hsp90 and CHIP on the maturation of ERG proteins in HL-1 mouse cardiac myocytes
We further evaluated the effects of Hsp90 and CHIP on endogenous mouse ERG using HL-1 cells. Immunoblotting with anti-mouse ERG antibody showed an intense 155 kDa band and a faint 135 kDa band. Overexpression of Hsp90 caused a significant increase of 155 kDa mature form and a slightly increase of 135 kDa immature form ( Figure 3A) . In contrast, overexpression of CHIP significantly decreased both forms of mouse ERG compared with HL-1 cells transfected with pcDNA3 ( Figure 3B ).
Effects of Hsp90 on mutant HERG proteins with trafficking defects
We also examined effects of Hsp90 on the interaction with CHIP and degradation of mutant HERG proteins with trafficking defects. The location of each mutation is depicted in Figure 4A . Only a single band, corresponding to the immature core-glycosylated protein, was detected in cells expressing the mutant HERG proteins, while there were two bands of mature and immature proteins in cells expressing WT ( Figure 4B) ; immunoprecipitation experiments indicated that the levels of CHIP associated with the channel proteins were higher in the mutants than in WT. Hsp90 overexpression decreased the binding of CHIP to the five mutant HERG proteins ( Figure 4C ). These results indicated that facilitated CHIP binding to the disease-causing mutant HERG proteins is attenuated by overexpressed Hsp90.
Effects of Hsp90 overexpression on a frameshift mutant HERG(1122fs/147)-FLAG protein
We further examined whether Hsp90 overexpression could affect maturation, ubiquitination, and the interaction with CHIP of a frameshift mutant HERG(1122fs/147)-FLAG which was found in LQT2 patients. 29 Anti-FLAG antibody recognized a 147 kDa immature band and a faint 167 kDa mature band. Overexpressed Hsp90 increased both the immature and mature proteins ( Figure 5A and B) , and decreased the ubiquitinated form of this mutant ( Figure 5C ). Overexpressed Hsp90 reduced the CHIP/HERG(1122fs/147)-FLAG protein complex, along with the increased Hsp90/HERG(1122fs/147)-FLAG protein complex ( Figure 5D) . CHIP decreased the level of HERG(1122fs/147)-FLAG proteins in a dosedependent manner, even in the absence of GA ( Figure 5E ). MG132 antagonized the action of CHIP on the HERG(1122fs/147)-FLAG protein ( Figure 5F ). These results indicate that CHIP binds to HERG(1122fs/ 147)-FLAG proteins to facilitate their degradation via UPS. We next examined whether Hsp90 overexpression restored trafficking of HERG(1122fs/147)-FLAG proteins and the mutant-mediated Hsp90 prevents CHIP-HERG protein interaction membrane current. Confocal imaging indicated that HERG(1122fs/ 147)-FLAG proteins localized predominantly in the ER and Golgi but not on the cell surface, which was confirmed by the co-localization with DsRed2-ER ( Figure 6A ; nos. 1-3), DsRed-Monomer-Golgi ( Figure 6A ; nos. 4 to 6) and PM-mKeima-Red ( Figure 6A ; nos. 7-9). Overexpressed Hsp90 increased the expression of HERG(1122fs/ 147)-FLAG proteins on the cell surface as well as in the ER and Golgi in co-transfected cells ( Figure 6A ; nos. 10 -18), as determined quantitatively ( Figure 6B) .
Finally, the effects of Hsp90 on the mutant-mediated membrane currents were examined electrophysiologically. Both the peak and tail currents were much smaller in cells transfected with HERG(1122fs/ 147)-FLAG plasmid alone than in those transfected with WT HERG-FLAG ( Figure 6C ). Co-expressed Hsp90 enhanced both peak and tail currents in cells expressing the mutant, as confirmed by quantitative analysis ( Figure 6D ).
Discussion
Both Hsp90 inhibitors GA and radicicol decreased the mature form of WT HERG-FLAG proteins and increased the immature form, along with an increase of its ubiquitinated form; suppression of UPS by MG132 increased HERG-FLAG proteins even in the presence of GA (Figure 1 and see Supplementary material online, Figure S6 ). Hsp90 overexpression antagonized the inhibitory action of GA on the maturation of WT HERG-FLAG protein ( Figure 1A) , promoted its traffic to the plasma membrane (see Supplementary material online, Figure S4) , and increased the HERG channel current corresponding to I Kr in cells treated with GA (see Supplementary material online, Figure S5 ). These results, which are partly compatible with the previous report on the role of Hsp90 in maturation of HERG proteins, 8 suggest that Hsp90 facilitates the maturation of WT HERG-FLAG proteins and inhibits degradation of its immature form through UPS. The site of action of Hsp90 is likely the ER, since Hsp90 co-localized with HERG proteins in the ER (see Supplementary material online, Figure S2 ). Protein degradation in the cytoplasm and nucleus involves close cooperation of Hsp90 with UPS. It has recently been reported that the Hsp90/substrate complex is produced by substrate transfer to Hsp90 and Hsc70, which is promoted by simultaneous binding of Hop to both chaperones with subsequent replacement of Hsc70 and Hop by another co-chaperone, FKBP38. 30 In cells treated with GA, Hsp90 overexpression not only restored the mature form of the HERG-FLAG protein, but also increased its immature form with a reduction in its ubiquitinated form ( Figure 1A) , suggesting that overexpressed Hsp90 bound to the immature HERG-FLAG protein could prevent its interaction with UPS. CHIP, an E3 ubiquitin ligase crucial for ubiquitination of small Hsp client proteins, is reported to mediate ubiquitination of Hsc70-bound client proteins in conjunction with E2 enzymes of the Ubc 4/5 family and thereby induce client protein degradation by the 26S proteasome. 24 -26 In the present study, CHIP interacted with WT HERG-FLAG proteins to facilitate its degradation through UPS in cells treated with GA (Figure 2A) , while MG132 antagonized the degrading action of CHIP ( Figure 2C) . CHIP degraded the WT HERG protein only in cells treated with GA; the mechanism of this GA-dependent effect is unknown. The CHIP/HERG protein complex was decreased by Hsp90 overexpression with an increase in the Hsp90/HERG protein complex ( Figure 1A) , suggesting that the interaction between CHIP and HERG proteins is prevented by the Hsp90 binding to HERG proteins and facilitated by GA which dissociates Hsp90 from HERG proteins. It has been reported that GA blocks the interaction of Hsp90 with chaperone clients and dissociate Hsp90 from client proteins to stimulate the CHIP-mediated degradation of signalling proteins such as an oncogenic tyrosine kinase, ErbB2, 31 which is consistent with our finding. It has also been reported that overexpression of CHIP stimulated degradation of mutant p53 but not WT. 32 WT p53 possesses intrinsic conformational lability and therefore undergoes dynamic association with molecular chaperones at a post-translational stage. 31, 33 The HERG protein also possesses an intrinsic conformational labiality and may therefore undergo dynamic association with Hsp90 at a posttranslational stage, which may inhibit the interaction with CHIP and ubiquitination of HERG proteins. Taken together, Hsp90 stabilizes the immature form of HERG proteins by preventing the binding, as well as facilitating the release, of CHIP. The above finding may also be applicable to the disease-causing mutant HERG proteins. CHIP bound to the mutant HERG proteins Figure 4B) . Overexpressed Hsp90 attenuated the interaction of CHIP with the mutant HERG proteins ( Figure 4C) , and restored the expression of HERG(1122fs/147)-FLAG proteins ( Figure 6A ). HERG(1122fs/147) was found in Japanese patients with LQT2 who suffered from torsades de pointes ventricular tachycardia. 29 HERG(1122fs/147) proteins existed mainly in the immature coreglycosylated form with an increased level of the ubiquitinated form ( Figure 5C ), retained in the ER and was hardly transported to the plasma membrane ( Figure 6A ), thus resulting in smaller membrane currents ( Figure 6C) . The heterologously expressed HERG(1122fs/147) channel protein has been reported to generate smaller membrane currents, 29 which is in agreement with our findings.
Hsp90 overexpression increased the expression of both mature and immature forms of HERG(1122fs/147) channel proteins with a reduction of its ubiquitinated form ( Figure 5C ), increased the immunoreactivity both in the ER and on the cell surface ( Figure 6A) , and enhanced HERG channel currents ( Figure 6C and D) . Immunoprecipitation experiments indicated that Hsp90 overexpression decreased the CHIP/HERG (1122fs/147)-FLAG protein complex with an increase in the Hsp90/ HERG(1122fs/147)-FLAG protein complex ( Figure 5D ). CHIP overexpression reduced HERG(1122fs/147)-FLAG proteins with antagonism by MG132 ( Figure 5E and F ), indicating that the degradation of HERG (1122fs/147)-FLAG proteins through UPS can be regulated via a transient association of CHIP with HERG(1122fs/147)-FLAG proteins.
Stabilizing the mutant HERG proteins is expected to prevent ventricular arrhythmias in patients with LQT2 via enhancing I Kr . We observed the action of overexpressed Hsp90 or CHIP on ERG proteins in HL-1 cells as well (Figure 3) , suggesting that they actually regulate I Kr in cardiomyocytes. Thus, the enhancement of Hsp90 expression in the diseased heart might stabilize HERG mutants via inhibiting their interactions with CHIP, possibly providing a novel avenue to treat fatal arrhythmias in LQT2 caused by impaired traffic of HERG channel proteins.
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